Cargando…
MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases
BACKGROUND: The efficacy of salvage resection (SR) of recurrent brain metastases (BrM) post-stereotactic radiosurgery (SRS) is not well described. We sought to characterize the impact of adjuvant post-salvage radiation therapy (PSRT) in this setting and identify tumor-specific variables that influen...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351198/ http://dx.doi.org/10.1093/noajnl/vdab071.054 |
_version_ | 1783735921820041216 |
---|---|
author | Wilcox, Jessica Brown, Samantha Reiner, Anne Young, Robert Chen, Justin Bale, Tejus Rosenblum, Marc Newman, William Brennan, Cameron Tabar, Viviane Beal, Kathryn Panageas, Katherine Moss, Nelson |
author_facet | Wilcox, Jessica Brown, Samantha Reiner, Anne Young, Robert Chen, Justin Bale, Tejus Rosenblum, Marc Newman, William Brennan, Cameron Tabar, Viviane Beal, Kathryn Panageas, Katherine Moss, Nelson |
author_sort | Wilcox, Jessica |
collection | PubMed |
description | BACKGROUND: The efficacy of salvage resection (SR) of recurrent brain metastases (BrM) post-stereotactic radiosurgery (SRS) is not well described. We sought to characterize the impact of adjuvant post-salvage radiation therapy (PSRT) in this setting and identify tumor-specific variables that influence local control. METHODS: Retrospective analysis of post-SRS recurrent BrM that underwent SR between 2003–2020 at Memorial Sloan Kettering Cancer Center was performed. Cases with histologically-viable malignancy were included and stratified by receipt of adjuvant PSRT within 60 days of SR (PSRT cohort) vs. observation (observation cohort). Resection-site outcomes were described using cumulative incidences and univariate and multivariate competing risks regression accounting for clustering. RESULTS: One-hundred fifty-five recurrent BrM in 135 patients were included. Thirty-nine (25.2%) of the post-operative cavities were treated with adjuvant PSRT, and the remaining 116 (74.8%) cavities were initially observed. Gross- or near-total resection was associated with significantly improved local control compared to subtotal resection (p=0.007). Adjuvant PSRT was associated with a reduced rate of LR at 6 months [18.0% (95%CI: 9.8–33.1%) vs. 35.9% (95%CI: 27.9–46.2%) with initial observation] and 12 months [28.8% (95%CI: 17.0–48.8%) vs. 43.9% (95%CI: 36.2–53.4%)]. On multivariate analysis, adjuvant PSRT (p=0.095), low tumor-viability within the resected BrM (p=0.17), and first-time resection (p=0.035) all independently trended towards improved local control. BrM size at SR (≥3cm vs. <3cm, p=0.48), primary malignancy (p=0.35), and specific PSRT modality (whole or partial brain radiation vs. SRS, p=0.43) were not associated with differences in LR rate. Radiation necrosis (RN) was significantly increased in the PSRT cohort (HR 4.55, 95%CI: 1.26–16.39, p=0.02), though the total percentage with symptomatic RN remained low (PSRT cohort 5.1% vs observation cohort 0.9%). CONCLUSIONS: Local control after SR of a recurrent BrM may be optimized with gross- or near-total resection and adjuvant post-operative re-irradiation, with low symptomatic RN. |
format | Online Article Text |
id | pubmed-8351198 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-83511982021-08-09 MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases Wilcox, Jessica Brown, Samantha Reiner, Anne Young, Robert Chen, Justin Bale, Tejus Rosenblum, Marc Newman, William Brennan, Cameron Tabar, Viviane Beal, Kathryn Panageas, Katherine Moss, Nelson Neurooncol Adv Supplement Abstracts BACKGROUND: The efficacy of salvage resection (SR) of recurrent brain metastases (BrM) post-stereotactic radiosurgery (SRS) is not well described. We sought to characterize the impact of adjuvant post-salvage radiation therapy (PSRT) in this setting and identify tumor-specific variables that influence local control. METHODS: Retrospective analysis of post-SRS recurrent BrM that underwent SR between 2003–2020 at Memorial Sloan Kettering Cancer Center was performed. Cases with histologically-viable malignancy were included and stratified by receipt of adjuvant PSRT within 60 days of SR (PSRT cohort) vs. observation (observation cohort). Resection-site outcomes were described using cumulative incidences and univariate and multivariate competing risks regression accounting for clustering. RESULTS: One-hundred fifty-five recurrent BrM in 135 patients were included. Thirty-nine (25.2%) of the post-operative cavities were treated with adjuvant PSRT, and the remaining 116 (74.8%) cavities were initially observed. Gross- or near-total resection was associated with significantly improved local control compared to subtotal resection (p=0.007). Adjuvant PSRT was associated with a reduced rate of LR at 6 months [18.0% (95%CI: 9.8–33.1%) vs. 35.9% (95%CI: 27.9–46.2%) with initial observation] and 12 months [28.8% (95%CI: 17.0–48.8%) vs. 43.9% (95%CI: 36.2–53.4%)]. On multivariate analysis, adjuvant PSRT (p=0.095), low tumor-viability within the resected BrM (p=0.17), and first-time resection (p=0.035) all independently trended towards improved local control. BrM size at SR (≥3cm vs. <3cm, p=0.48), primary malignancy (p=0.35), and specific PSRT modality (whole or partial brain radiation vs. SRS, p=0.43) were not associated with differences in LR rate. Radiation necrosis (RN) was significantly increased in the PSRT cohort (HR 4.55, 95%CI: 1.26–16.39, p=0.02), though the total percentage with symptomatic RN remained low (PSRT cohort 5.1% vs observation cohort 0.9%). CONCLUSIONS: Local control after SR of a recurrent BrM may be optimized with gross- or near-total resection and adjuvant post-operative re-irradiation, with low symptomatic RN. Oxford University Press 2021-08-09 /pmc/articles/PMC8351198/ http://dx.doi.org/10.1093/noajnl/vdab071.054 Text en © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Supplement Abstracts Wilcox, Jessica Brown, Samantha Reiner, Anne Young, Robert Chen, Justin Bale, Tejus Rosenblum, Marc Newman, William Brennan, Cameron Tabar, Viviane Beal, Kathryn Panageas, Katherine Moss, Nelson MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases |
title | MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases |
title_full | MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases |
title_fullStr | MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases |
title_full_unstemmed | MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases |
title_short | MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases |
title_sort | mlti-05. adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases |
topic | Supplement Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351198/ http://dx.doi.org/10.1093/noajnl/vdab071.054 |
work_keys_str_mv | AT wilcoxjessica mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases AT brownsamantha mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases AT reineranne mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases AT youngrobert mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases AT chenjustin mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases AT baletejus mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases AT rosenblummarc mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases AT newmanwilliam mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases AT brennancameron mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases AT tabarviviane mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases AT bealkathryn mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases AT panageaskatherine mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases AT mossnelson mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases |